Stay updated on AK002 for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the AK002 for Eosinophilic Gastritis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe NCT04322604 record for the lirentelimab (AK002) Phase 3 study is now available instead of an error page. The page includes detailed trial information and study documents, including the statistical analysis plan and protocol.SummaryDifference77%

- Check15 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0, while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on a page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision: v3.7.0 was added to the page, indicating a new version of the page. This update does not change trial details or documents displayed.SummaryDifference18%

Stay in the know with updates to AK002 for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.